TrialMedical oncology (Northwood, London, England)2013

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Antonio Rozzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.